Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML

Condition:   Acute Myeloid Leukemia (AML) Interventions:   Drug: Pevonedistat;   Procedure: transplant;   Drug: Azacitidine Sponsors:   Milton S. Hershey Medical Center;   Millennium Pharmaceuticals, Inc.;   Takeda Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials